Abstract: The present invention relates to a biodegradable multi-layer packaging element, such as a foil or wrap, for a food product, a food packaging unit comprising such multi-layer and a method for manufacturing such biodegradable multi-layer, with the multi-layer comprising: —an inner cover layer comprising an amount of a biodegradable aliphatic polyester; —a first intermediate layer of a biodegradable material for connecting and/or sealing adjacent layers; —a functional layer comprising a vinyl alcohol polymer; —a second intermediate layer of a biodegradable material for connecting and/or sealing adjacent layers; and —an outer cover layer comprising an amount of a biodegradable aliphatic polyester.

Abstract: The present invention relates to a biodegradable food packaging unit from a moulded or fluff pulp material and a method for manufacturing such biodegradable packaging unit. The packaging according to the invention comprises a food receiving and/or carrying compartment that comprises a biodegradable laminated multi-layer, with the multi-layer comprising: —an inner cover layer comprising an amount of a biodegradable aliphatic polyester; —a first intermediate layer of a biodegradable material for connecting and/or sealing adjacent layers; —a functional layer comprising a vinyl alcohol polymer; —a second intermediate layer of a biodegradable material for connecting and/or sealing adjacent layers; and—an outer cover layer comprising an amount of a biodegradable aliphatic polyester, and wherein the food packaging unit is a compostable food packaging unit.

Abstract: The present invention relates to a biodegradable food packaging unit (2) from a moulded pulp material and a method for manufacturing such biodegradable packaging unit. The packaging according to the invention comprises a food receiving or carrying compartment having a food contact surface, wherein the moulded pulp material comprises an amount of a biodegradable aliphatic polyester; wherein the food contact surface comprises a cellulose-based laminate layer (10); and wherein the food packaging unit is a compostable food packaging unit. In a preferred embodiment the amount of biodegradable aliphatic polyester is in the range of 0.5-20 wt. %, more preferably in the range of 1-15 wt. %.

Abstract: The present invention relates to a packaging unit (2) for a moulded pulp material and a manufacturing process therefore. The packaging unit according to the invention comprises a product receiving or carrying compartment having a product contact surface, wherein the product contact surface comprises a peelable laminate layer (10). In a presently preferred embodiment the moulded pulp material comprises an amount of a bio-degradable aliphatic polyester.

Abstract: The present invention relates to a method for manufacturing a 3-dimensional shaped product from a fluff pulp material and such product. The method according to the invention comprises the steps of: providing a fluff pulp material; providing an air-laid flow of fluff pulp material to a 3-dimensional shaped mould; forming the product in the mould; and releasing the 3-dimensional shaped product from the mould.

Abstract: An expansion tank (1) which is intended to be connected to a pipe system which is filled or is to be filled with liquid, comprises a substantially closed tank (2) having at least a first connection opening (6) for connection to a liquid pipe, a second connection opening for connection to a source of pressurized gas (14), and an element (8) which can move inside the tank and is designed to move with the interface (11) between liquid (9) and gas (10) in the tank. The tank is provided, at the location of the second connection opening, with a valve assembly (7) which can open and close the second connection opening and can be actuated by the movable element (8) in the tank.

Abstract: The present invention is directed to a tetrazole derivative represented by the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 independently represent a hydrogen atom, a hydroxyl group, a lower alkyl group, a substituted or unsubstituted alkoxy group, or a substituted or unsubstituted alkanoyloxy group; R.sup.3 represents a hydrogen atom or a substituted or unsubstituted lower alkyl group; A represents a methyleneoxy group or a vinylene group; B represents a substituted or unsubstituted quinolyl group, a substituted or unsubstituted quinazolyl group, or a substituted or unsubstituted benzimidazolyl group; and a broken line indicates that there may be a double bond; and to a medicine containing the compound as an active ingredient. The medicine according to the present invention is endowed with excellent antileukotriene activity and antihistaminic activity, and is useful for the prevention and treatment of, for example, asthma.

Abstract: The present invention is directed to a tetrazole derivative represented by the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 independently represent a hydrogen atom, a hydroxyl group, a lower alkyl group, a substituted or unsubstituted alkoxy group, or a substituted or unsubstituted alkanoyloxy group; R.sup.3 represents a hydrogen atom or a substituted or unsubstituted lower alkyl group; A represents a methyleneoxy group or a vinylene group; Z represents a substituted or unsubstituted benzimidazolyl group; and a broken line indicates that there may be a double bond; and to a medicine containing the compound as an active ingredient. The medicine according to the present invention is endowed with excellent antileukotriene activity and antihistaminic activity, and is useful for the prevention and treatment of, for example, asthma.

Abstract: The present invention is directed to a piperidine derivative represented by the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1, R.sup.2, and R.sup.3 individually represent hydrogen atoms, etc., Y represents ##STR2## B represents a single bond, an alkylene group, --S--CH.sub.2 --, or --CH.dbd.CH--, E represents a single bond or a trimethylene group, Z represents an oxygen atom, etc., and n represents a number between 2 and 5 inclusive; and to a medicine containing the compound. The medicine according to the present invention is endowed with excellent anti-histaminic activity and antileukotriene activity, and exhibits reduced side effects such as drowsiness.

Abstract: Compounds of the formula (I): Ar.sub.1 --CH(OH)--CH.sub.2 --NH--CH.sub.2 --X--CH.sub.2 --E--(CH.sub.2).sub.n --Y--Ar.sub.2, in which the substituents and symbols have the meanings given in the description, are novel active compounds having, in particular, a broncholytic action.

Abstract: Thiazolidine derivatives containing at least one organic nitrate ester group have cardiovascular activity.

Abstract: Compounds a formula (I) ##STR1## wherein the substituents and symbols have the meanings given in the specification, are new compounds with marked cardiovascular activity.

Abstract: A process is provided for preparing novel substituted or unsubstituted 4(5)-.omega.-aminoalkyl)imidazoles of the formula ##STR1## wherein n is 1 to 6, R.sub.1 is hydrogen or a linear, branched or cyclic, saturated or unsaturated alkyl group having 1-6 C-atoms or a phenyl ring being unsubstituted, or mono- or di-substituted with groups such as lower alkyl, halogen, alkoxy, methylenedioxy or a combination thereof, and R.sub.2 is hydrogen or methyl. The process comprises brominating an .omega.-phthalimidoalkan-2-one with bromine in anhydrous methanol to a 1- or 3-bromo-.omega.-phthalimido-alkan-2-one, subjecting said derivative to ring closure with an amidine in N.N-dimethylformamide with potassium carbonate under mild conditions followed by hydrolytic separation of the phthalic residue. Pharmaceutical compounds, compositions and a method of treatment are also provided.

Abstract: The invention relates to a benzhydryl derivative having the formula ##STR1## wherein each of the groups R.sub.1, R.sub.2, and R.sub.3 represents one to four substituents independently selected from the group consisting of hydrogen, lower alkyl, halogen, and CF.sub.3, and at least one of the groups R.sub.1, R.sub.2, and R.sub.3 is halogen or CF.sub.3 ;R.sub.4 represents hydrogen or methyl;n is 2, 3, or 4;m is 1, 2, or 3; andX represents O or S;or its pharmaceutically acceptable salts.The benzhydryl derivative of the invention can be used to treat patients who are suffering from diseases which are influenced by calmodulin.

Abstract: The invention relates to pharmaceutical compositions containing novel nitrate esters, of which it was found that they are useful for the treatment of ischemiatic heart diseases, decompensatio cordis, myocardial infarction and hypertension.

Abstract: The invention relates to novel quinazoline and isoquinoline derivatives of the general formula: ##STR1## and acid addition salts and copper complexes thereof, wherein X represents nitrogen or a CH group,Y represents oxygen or an NH group,R.sub.1 and R.sub.2 represent hydrogen, alkyl(1-6 C), alkoxy (1-6 C), halogen or trifluoromethyl,R.sub.3 represents a substituted or unsubstituted 2-pyridyl group andR.sub.4 represents hydrogen, an alkyl(1-6 C) group unsubstituted or substituted by halogen, alkoxy (1-6 C) or phenyl groups, a cyclic alkyl group or a substituted or unsubstituted aromatic group.